Skip to main content
Explore URMC

menu

Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Waldenström Macroglobulinemia

Research Question:
What is the response of the immune system when patients with chronic lymphocytic leukemia are vaccinated with the Shingrix herpes zoster vaccine?

Basic Study Information

Purpose:
The purpose of this study is to measure humoral response 4 weeks after vaccination with the Shingrix herpes zoster vaccine in patients with CLL and WM undergoing first-line treatment with BTK inhibitors.

Study Reference #: ULYM18094

Lead Researcher (Principal Investigator)

Lead Researcher: Jonathan Friedberg, MD

Study Contact Information

Study Coordinator: Delaney Dretto
Phone: (585) 275-5825

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search